Dual Approach Aids Depression Treatment (Depression News)
Wall Street Journal - A combination of medication and therapy helps depressed adolescents heal faster than medication or therapy alone, and with fewer incidents of the suicidal tendencies associated with unalloyed antidepressant use, according to findings in the largest Read more
Investors Business Daily - Revenue climbed 19% to $4.59 billion, helped by a 47% increase in sales of depression treatment Cymbalta. Pfizer ( PFE ) also topped views when it reported Oct. 18, though its stock fell that day. Analysts cited lower quarterly sales amid generic Read more
Street.Com - The stock is 33% off of its highs because it remains unclear if its depression-treatment system will have any material effect on patients. That said, if this stock should hear one piece of good news, it will get pushed up past $30. Icahn tends to Read more
BusinessWeek - Eli Lilly & Co. said Thursday its third-quarter profit rose percent on strong sales of drugs such as its Cymbalta depression treatment, and it raised its outlook for the year. The drug maker said net income rose 6 percent to $926.3 million, or 85 Read more
CNBC - SEB Enskilda upped its stance on the Lundbeck stock to ‘buy’ from ‘hold’ and raised its target price following the news about the AA21004 depression treatment candidate earlier this week. Coloplast was up 2 at 502, while Novo Nordisk B fell 7 to 627 Read more
